Company / Book Value per Share
Immunome Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$9.841
FY2025
5-year range
$1.373 / $9.841
FY2021-FY2025
Trend
+255.0%
vs FY2024
Sector context
#56 of 209
Health Care
What the data says
Book Value per Share changed +255% YoY in FY2025, a notable deviation from the 6-year average annual change of +60%.
Based on SEC 10-K filings.
$9.841 in FY2025 with a 5-year CAGR of -4.2%.
Improved from $1.373 to $9.841 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +92.8%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Sector benchmark
#56 of 209 in Health CareTop 27% of 209This company $9.841 Sector average $215.686
▼
-95.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.2%, indicating a declining trend.
- In FY2025, book value per share increased 255.0% year-over-year.
- Ranks #56 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.841 | +255.0% |
| FY2024 | $2.772 | +101.9% |
| FY2023 | $1.373 | -0.0% |
| FY2022 | $1.373 | -67.1% |
| FY2021 | $4.176 | -65.8% |
| FY2020 | $12.198 | +137.5% |
| FY2019 | -$32.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026